Zyga Technology Inc, headquartered in Minnetonka, Minn, announces in a news release that it has received 510(k) clearance by the US Food and Drug Administration for its SImmetry Sacroiliac Joint Fusion System.
According to the release, the SImmetry Sacroiliac Joint Fusion System is a minimally invasive procedure that is intended for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
The 510(k) clearance enables the procedure to be performed using either a two-incision or a single-incision technique, the release notes.
“This new SImmetry technique allows me to offer patients a single, one-inch incision and to adapt the surgery to their individual anatomy and condition,” says David Greenwald, MD, of the Flagler Brain and Spine Institute in St. Augustine, in the release.
In January 2015, the Centers for Medicare and Medicaid Services assigned a Category 1 CPT code to minimally invasive SI joint fusion, improving patient access to the procedure, per the release.
For more information, visit Zyga Technology Inc.
[Source: Zyga Technology Inc]
